GI & Endoscopy

Austin, Texas-based XBiotech has entered a research collaboration with Fabio Cominelli, MD, PhD.

Dublin, Ireland-based Allergan has partnered with the world champion paratriathlete Amy Dixon.

Samuel C. Somers, MD, is a gastroenterologist at Concord-based GI Associates of New Hampshire.

Here are five updates on gastroenterology and endoscopy companies.

A study in OncologyNurseAdvisor clarified the role of a nurse navigator during a colonoscopy screening.

Boston-based NinePoint Medical is benefiting from CMS' updated final fee schedule with its NvisionVLE Imaging System meeting criteria for a substantial increase in reimbursement.

New Haven, Conn.-based Alexion Pharmaceuticals has released data from studies related to the Phase 3 ARISE trial of Kanuma. Kanuma, or sebelipase alfa, is a drug treatment for lysosomal acid lipase deficiency.

New York-based Intercept Pharmaceuticals has released data from three studies related to the Phase 3 POISE trial of Ocaliva. The POISE trial tested daily Ocaliva treatment in patients with primary biliary cholangitis with an inadequate therapeutic response to ursodeoxycholic acid.

Richard Dumois, MD, is a gastroenterologist at Orlando, Fla.-based Central Florida Gastroenterology.

The Woodlands, Texas-based McKesson Specialty Health is launching its in-office dispensing solution in local rheumatology and gastroenterology practices.